Cure Rare Disease, a clinical-stage nonprofit biotechnology company, has been awarded an advocacy collaboration grant from the Muscular Dystrophy Association (MDA) to support research on novel...
Fresenius Kabi announced the immediate availability in the U.S. of Stimufend, the company’s biosimilar to Neulasta, for use in patients at risk for febrile...
Carevive Systems, Inc. a leading innovator in cancer care management software with a deep real-world evidence patient dataset, announced that it will launch the...
Mercury Insurance has been recognized as one of America’s Best Midsize Employers for 2023 by Forbes. Forbes partnered with market research group Statista to...
